Skip to content

Systemic Lupus Erythematosus Susceptibility To 5 C1835929

Published: July 22, 2026Updated: August 27, 2026

A genetic susceptibility factor that may increase the likelihood of developing systemic lupus erythematosus, a chronic autoimmune condition. It affects individuals carrying this genetic marker. Ongoing monitoring and treatment by specialists helps manage lupus symptoms.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 27, 2026Editorial policy

Key facts at a glance

ICD-10
D89.9
ICD-11
3A00.0
Body system
immunologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Neurological seizures

!

Serositis

Generalized symptoms

(immunologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Oral ulcers

(mucosal)

Photosensitivity

(dermatologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Lifestyle modification and dietary intervention

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Photoprotection Protocol

Comprehensive sun avoidance strategies including wearing UPF-protective clothing, wide-brimmed hats, and UV-blocking sunglasses. Daily application of mineral-based sunscreens and seeking shade during peak hours.

lifestyle
3

Immunomodulatory Therapy

Disease-modifying medications that regulate abnormal immune responses characteristic of lupus. These agents help prevent organ damage and reduce flare frequency when disease activity persists.

medication

Additional treatment options

Chronic Illness Coping Support

Psychological counseling and support groups to address the emotional challenges of living with a chronic autoimmune condition. Helps manage anxiety, depression, and disease-related stress.

psychological

Organ System Surveillance

Regular screening for renal, cardiac, pulmonary, and neurological involvement through imaging, laboratory studies, and clinical examinations. Early detection allows for timely intervention.

monitoring

Vitamin D Supplementation

Assessment and supplementation of vitamin D levels, as many lupus patients have deficiency which may contribute to disease activity. Sun avoidance increases risk of deficiency.

dietary

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Systemic Lupus Erythematosus Susceptibility To 5 C1835929?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Petri M, Orbai AM, Alarcón GS, et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012.

guideline2012View source →
2

Tsokos GC. Systemic lupus erythematosus. N Engl J Med. 2011.

review2011View source →
3

Lee YH, Song GG. Association between BANK1 rs3733197 polymorphism and susceptibility to systemic lupus erythematosus: a meta-analysis. Lupus. 2013.

meta_analysis2013View source →
4

Merrill JT, Neuwelt CM, Wallace DJ, et al. Efficacy and safety of rituximab: results of a randomized double-blind placebo-controlled phase III trial in moderate-to-severe systemic lupus erythematosus. Arthritis Rheum. 2010.

clinical_trial2010View source →

Medication Comparisons

Compare medications used to treat Systemic Lupus Erythematosus Susceptibility To 5 C1835929. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 27, 2026. · Read our editorial policy